Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
Boston Scientific expands Farapulse afib reach with new approval
In its first year on the market, Farapulse brought in more than $1 billion in revenue. Now, Boston Scientific aims to reach the full afib population.
Conor Hale
Jul 7, 2025 11:58am
Novartis pens ProFound pact for cardiovascular disease targets
Jun 26, 2025 6:30am
Atraverse Medical raises $29.4M for left-heart access system
Jun 13, 2025 11:23am
Boston Scientific pulls Acurate TAVR implants from market
May 28, 2025 11:01am
Abbott snags US approval for mitral valve replacement implant
May 27, 2025 10:30am
Philips to test ultralow-dose X-ray technique in cath lab study
May 20, 2025 2:30pm
